Treatments and vaccines for COVID-19

Medicines authorised in the European Union (EU) to treat or prevent COVID-19, following a scientific evaluation by the European Medicines Agency (EMA). It provides details on the other potential treatments and vaccines that EMA is evaluating or has provided support to during research and development.

In this section


COVID-19 vaccines

COVID-19 vaccines under investigation, evaluation and authorised for use in the EU

COVID-19 treatments

COVID-19 treatments under investigation, evaluation and authorised for use in the EU

Monitoring of COVID-19 medicines

How EMA is monitoring safety and effectiveness of COVID-19 medicines.

Transparency: exceptional measures for COVID-19 medicines

EMA's exceptional measures to ensure its regulatory activities in relation to COVID-19 medicines are as transparent as possible. 

EMA is assessing all applications for COVID-19 treatments and vaccines under the minimum timeframe necessary to allow a thorough evaluation of the medicine's benefits and risks, in accordance with its usual standards for qualitysafety and efficacy.

Press briefings

EMA holds press briefings to announce breaking news and explain its latest scientific work in tackling the COVID-19 pandemic:


How useful was this page?

Add your rating
50 ratings
18 ratings
12 ratings
15 ratings
113 ratings